MDTK · Bryn
21 filings
MDTK 8-K Current Reports
Bryn - 21 current reports
MDTK filed 9 annual reports (10-K), 10 quarterly reports (10-Q) and 6 current reports (8-K) between 2020 and 2026.
- 10-K · Jul 21, 2020
- 10-Q · Aug 3, 2020
- 10-K/A · Sep 23, 2020
- 8-K · Sep 28, 2020
- 8-K · Dec 1, 2020
- 10-Q · Dec 4, 2020
- 8-K · Feb 10, 2021
- 8-K · Feb 16, 2021
- 10-K · Dec 19, 2024
- 10-K/A · Dec 19, 2024
- 10-K · Dec 30, 2024
- 10-K · Jan 3, 2025
- 10-K · Jan 6, 2025
- 10-Q · Jan 13, 2025
- 10-Q · Jan 13, 2025
- 10-Q · Jan 13, 2025
- 10-K · Apr 15, 2025
- 10-Q · May 21, 2025
- 10-Q · Jul 24, 2025
- 10-Q · Oct 21, 2025
- 10-K · Apr 2, 2026
- 8-K · May 11, 2026
- 10-Q · May 19, 2026
- 10-Q · Aug 14, 2026
- 8-K · Sep 16, 2026
Bryn 8-K Report, Bylaw Amendment (Sep 16, 2026)
Byrn, Inc. (BRRN) has filed an 8-K announcing significant corporate changes set to take effect on September 23, 2026. Most notably, the company will undergo a substantial one-for-one-hundred-thousand (1-for-100,000) reverse stock split. This action is designed to dramatically reduce the number of outstanding shares. Additionally, the company will officially change its name to MEDO Technologies, Inc., and has applied to trade under the ticker symbol "MEDO". This reverse stock split is an aggressive move that will impact all shareholders. Those holding fewer than 100,000 shares prior to the split will receive a nominal cash payment of $0.00007 per share, effectively cashing them out. Holders of 100,000 or more shares will have fractional shares rounded up to the nearest whole share. The adjusted trading is expected to commence on the OTCID Market on September 24, 2026, with a new CUSIP number. Investors should carefully consider the implications of this significant share consolidation.
Bryn 8-K Report, Change in Control (May 11, 2026)
Byrn, Inc. (BRRN) has undergone a significant change in control and leadership. MEDO Healthcare LLC has acquired a controlling stake of approximately 84.7% of the company's voting power through the purchase of 10 million shares of Series A-1 Preferred Stock for $175,000. This transaction, which occurred on April 24, 2026, has resulted in a substantial shift in beneficial ownership, with Jean Christophe Chopin now holding 63.1% of the common stock, but MEDO Healthcare LLC wielding dominant voting power due to the preferred stock. Concurrently, David Lazar has resigned as the sole director and officer. John Leo has been appointed as the new Chief Executive Officer and sole director, and Arthur Magee has been appointed as CFO and Secretary. Both Leo and Magee bring extensive experience in investment banking and corporate finance from Primary Capital LLC, suggesting a strategic focus on financial operations and potential growth initiatives.
Bryn 8-K Report, Material Agreement (Feb 16, 2021)
This 8-K filing from Born, Inc. (BRRN) details a significant corporate transformation, primarily through a share exchange agreement with Alkeon Creators, Inc. effective February 16, 2021. This transaction has been accounted for as a recapitalization, with Alkeon being the accounting acquirer. This strategic move has effectively resulted in a reverse merger, with the former stockholders of Alkeon now holding a majority of the outstanding common stock and Born, Inc. ceasing to be a shell company. The company has also undergone a name change from Quture International, Inc. to Born Inc. and a 1-for-1,000 reverse stock split. The company is repositioning itself as a holding company specializing in digital, data-led solutions for retail supply chains, operating through its subsidiary Alkeon. Alkeon provides B2B solutions for digitizing tradeshows and showrooms, alongside the Born.com platform that connects luxury design brands with retailers. The business model is primarily subscription-based. The filing also highlights a change in leadership with Mr. Jean Christophe Chopin appointed as the sole officer and director, replacing Mr. Wieland Kreuder.
Bryn 8-K Report, Bylaw Amendment (Feb 10, 2021)
This Form 8-K, filed February 10, 2021 by Born, Inc. (a Nevada corporation; the request refers to it as Byrn, Inc. (BRRN), but the filing itself names Born, Inc.), reports a single corporate action under Item 5.03: the Board changed the company's fiscal year end to December 31. The sole director, Wieland Kreuder, approved the change by written consent on February 4, 2021. The stated reason is to align the company's fiscal year with that of its intended subsidiary, Alkeaon Creators Inc. The filing does not disclose the prior fiscal year end, any transition period, or the financial impact of the change. The cover page lists no securities registered under Section 12(b), and the trading symbol and exchange fields are all marked N/A. The company therefore appears to have no exchange-listed securities, which makes this filing an administrative disclosure rather than an operating update. Exhibit 99.1 contains the sole director's resolutions, which also ratify prior company actions and authorize officers to make the necessary filings. For investors, the filing signals an early-stage or restructuring-phase company preparing to acquire or form a subsidiary, and it provides no revenue, earnings, balance sheet, or deal terms. Any investment thesis would depend on later filings that describe the Alkeaon Creators relationship and the company's financial condition.
Bryn 8-K Report, Bylaw Amendment (Dec 1, 2020)
Byrn, Inc. (BRRN), formerly Quture International, Inc., has filed an 8-K report detailing significant corporate actions taken on November 24, 2020, and effective December 1, 2020. The company has officially changed its name to Byrn, Inc. and executed a 1-for-1,000 reverse stock split. These changes are strategically positioned in anticipation of the company entering a new line of business operations. Investors should note that FINRA has declared these changes effective as of December 1, 2020. Furthermore, the company was informed that its ticker symbol will be updated to BRRN within twenty business days. This rebranding and restructuring signals a potential shift in the company's strategic direction, and investors should monitor future filings for details regarding the new business ventures.
Bryn 8-K Report, Change in Control (Sep 28, 2020)
This 8-K reports a change in control of Quture International, Inc. (Nevada). On September 23, 2020, Custodian Ventures, LLC transferred 10,000,000 shares of Series A Convertible Preferred Stock to FiveT Capital Holding AG for $265,000 in cash from the purchaser's personal funds. The filing says the purchaser now holds about 50.2% of the voting rights on a fully diluted basis and is the controlling shareholder. Note that the filing names Quture International, Inc., not Byrn, Inc. (BRRN) as stated in the request, so the ticker and company identity should be verified before relying on this analysis. Leadership changed at closing. David Lazar resigned as CEO, CFO, President, Treasurer, Secretary, and director. Wieland Kreuder, a 46-year-old FiveT Capital AG executive, took over all of those roles and became Chairman. Separately, a September 10, 2020 Certificate of Designation changed the Series A preferred conversion and voting terms to 250 for each share. The Stock Purchase Agreement states that the preferred converts into 21,000,000,000 common shares, which would be a substantial dilution risk for existing common holders. The company appears to have no operating business. The purchase agreement says the buyer assumes the risk of undisclosed liabilities, and it describes the company as having no current business operations or plans. The agreement also requires the buyer to pay off third-party payables and waives about $21,950 in debt owed to the seller and Lazar. Investors should treat this as a shell-company control transaction, with the main concerns being the large potential conversion dilution, the lack of disclosed business plans, and the limited diligence available to the buyer.
Bryn 8-K/A Report, Auditor Change (Mar 11, 2013)
Quture International, Inc. (BRRN) filed an amendment to its Form 8-K on March 11, 2013, to correct a date referenced in a prior filing. The primary focus of this amended filing is to disclose a change in the company's independent registered public accounting firm. Effective March 4, 2013, the company terminated its relationship with R.R. Hawkins & Associates International, PC ('Hawkins'). This change in auditors is significant for investors as it comes with specific disclosures regarding the prior auditor's reports. While Hawkins' reports for the fiscal years ended April 30, 2012, and 2011, did not contain any adverse opinions or disclaimers, they did include an explanatory paragraph raising substantial doubt about the company's ability to continue as a going concern. Importantly, the company states there were no disagreements with Hawkins on accounting principles, financial statement disclosures, or auditing procedures that would have led to a reference in Hawkins' reports.
Bryn 8-K Report, Auditor Change (Mar 8, 2013)
Quture International, Inc. (formerly Byrn, Inc.) filed an 8-K on March 8, 2013, reporting a change in its independent registered public accounting firm. The company dismissed R.R. Hawkins & Associates International, PC, effective March 4, 2013. The prior auditor's reports contained an explanatory paragraph highlighting substantial doubt about the company's ability to continue as a going concern, though there were no disagreements on accounting principles or financial reporting. Subsequently, on March 5, 2013, Quture International engaged DKM Certified Public Accountants as its new auditor. The company stated that it did not consult with DKM prior to this engagement on any matters that would be considered reportable events. This change in auditors, especially given the going concern issue raised by the previous firm, is a significant development for investors to monitor, as it could signal underlying financial challenges or a strategic shift in how the company addresses its financial reporting.
Bryn 8-K Report, Executive Changes (Mar 5, 2013)
Quture International, Inc. (BRRN) has filed an 8-K report detailing the resignation of Barry Hollander as Chief Financial Officer (CFO) and Director. Mr. Hollander's resignation as CFO and from the subsidiary ZenZuu USA, Inc. was effective February 28, 2013, and his departure as Director will be effective March 29, 2013. This event signifies a leadership transition within the company, prompting the search for a new CFO. Notably, the company and Mr. Hollander are negotiating a Separation and Settlement Agreement. Key terms include a $35,000 note payable for accrued and unpaid fees, to be settled in two installments of $5,000 each by March 15 and March 31, 2013. Failure to meet these payment deadlines would render the entire note immediately due. Mr. Hollander will retain his substantial beneficial ownership of 27,908,007 shares of common stock. The resignation was not due to any material disagreements with the company's operations, policies, or practices.
Bryn 8-K Report, Bylaw Amendment (Sep 14, 2012)
This Form 8-K reports a corporate name change and ticker update rather than a financial or operational event. Techs Loanstar, Inc. (Nevada) changed its legal name to Quture International, Inc. via Amended and Restated Articles of Incorporation, which the filing says were approved by a majority of shareholders and the Board. FINRA approved the name change on September 4, 2012, and the stock began trading under the OTCQB symbol QUTR on September 5, 2012. The prompt identifies the ticker as BRRN, but the filing shows the company trading as QUTR, and the filing itself is for Techs Loanstar / Quture International rather than Byrn, Inc. The filing contains no financial statements (Item 9.01 is marked not applicable), so investors cannot assess profitability, liquidity, or cash flow from it. The accompanying press release describes Quture as an emerging growth company that aims to become a leading clinical knowledge company, operating through subsidiaries in North America and Europe and linked to a planned Qx Medical Exchange. The release also presents the company's stated strategy and milestones in promotional terms without quantified results. Two details warrant caution. The filing notes a February 15, 2012 Nevada filing date for the amendment but was not reported until September 2012, a gap of roughly seven months that investors may want to understand. The forward-looking statements explicitly cite the company's ability to continue as a going concern, a signal that its financial condition is fragile and that the company's projections should be treated skeptically until supported by audited financials.
Bryn 8-K Report, Executive Changes (Jan 19, 2012)
This Form 8-K filing by Techs Loanstar, Inc. (TCLN) reports a significant leadership change within its wholly-owned subsidiary, Quture, Inc. Effective January 13, 2012, Dr. Richard D. Fantozzi has been appointed as the Chief Executive Officer of Quture and Co-Chairman of its Board of Directors. Dr. Fantozzi brings a wealth of experience from his distinguished medical career, including leadership roles in medical boards and private practice, as well as experience in real estate investment through RDF Asset Group, Inc. His appointment is intended to leverage his prominence, expertise, and business leadership for Quture's growth. In conjunction with this appointment, Mr. G. Landon Feazell has stepped down as CEO of Quture but will retain his roles as Co-Chairman of Quture's Board and as CEO, President, and Chairman of the Board of the parent company, Techs Loanstar, Inc. The compensation for Dr. Fantozzi includes 100,000,000 restricted shares of the company's common stock and a monthly salary of $6,500.
Bryn 8-K Report, Executive Changes (Nov 9, 2011)
Techs Loanstar, Inc. (now Byrn, Inc., BRRN) filed an 8-K on November 9, 2011, to report a significant appointment. On November 7, 2011, the company appointed Dr. Reid Jilek as Chairman of its Scientific and Business Advisory Boards. This appointment brings a wealth of experience in healthcare advisory, consulting, and business development across various sectors including pharmaceuticals, diagnostics, and medical devices. Dr. Jilek's extensive background includes senior roles at Asia Pacific Alliance Company, Transgenic Sciences Inc., and Frederick Research Center, along with current VP Business Development at Eveia Medical, Inc. His compensation package includes 25,000,000 restricted shares of common stock and a monthly retainer of $5,000, contingent upon a successful capital raise of at least $500,000. This move signals a strategic effort by Techs Loanstar to bolster its expertise and potentially drive growth in the healthcare and life sciences sectors.
Bryn 8-K/A Report, Material Agreement (Sep 22, 2011)
On August 9, 2011, Techs Loanstar, Inc. (OTCQB: TCLN) completed a reverse merger with Quture, Inc., a Nevada healthcare knowledge solutions company that develops clinical performance and outcomes measurement software (QualOptima and QSurg) built on InterSystems' platform. Techs Loanstar issued 1,938,543,110 new common shares to Quture's sole shareholder, Starslide Global Holdings (controlled by G. Landon Feazell), giving Quture holders roughly 85% of the company's 2,280,638,953 outstanding shares. The authorized share count was increased from 900 million to 2.51 billion to accommodate the issuance. Management was reconstituted, with Feazell becoming CEO, President and Chairman, and Henry Fong resigning. This 8-K/A was filed mainly to provide the 'Form 10 information' required under Rule 144 following the acquisition, and it includes Quture's audited July 31, 2011 financials, Q3, LLC's audited and interim financials, and pro forma statements. The financial picture is weak. Quture's audited balance sheet at July 31, 2011 shows total assets of only $5,883 against liabilities of $374,784, a stockholders' deficit of $368,901, and an accumulated deficit of $3.38 million. Its inception-to-date net loss was $11,034 on $26,000 of revenue, nearly all from a single customer. The pro forma combined balance sheet shows a total stockholders' deficit of about $1.67 million and total liabilities of $1.71 million, including related-party payables and advances, convertible notes, and a derivative liability. The auditor (R.R. Hawkins & Associates) included a going-concern paragraph, and management states the company has no full-time employees and depends on related-party funding and future financing. For investors, the key points are the massive dilution (existing shareholders retain about 15%), a change of control concentrated in one insider holding about 70% of voting power, the early-stage and unproven product base with a sole licensed technology partner, and a going-concern qualification. The filing contains no revenue guidance and no near-term financing commitments, so the investment case rests on the successful commercialization of an untested platform by a company with very limited cash.
Bryn 8-K Report, Material Agreement (Aug 12, 2011)
On August 9, 2011, Techs Loanstar, Inc. (OTCQB: TCLN) closed a First Amendment to its Exchange Agreement with Quture, Inc., a Nevada healthcare knowledge solutions company that provides clinical performance measurement tools to healthcare organizations, insurers, and government payers. Under the transaction, Techs Loanstar agreed to issue an aggregate of 1,938,543,110 shares of common stock to Quture's shareholders in a tax-free exchange, making Quture a wholly-owned subsidiary. Only 400,000,000 shares are issued initially; the remaining 1,538,543,110 shares are to follow after a shareholder-approved increase in authorized shares. Post-closing, Quture's shareholders are expected to own approximately 85% of the outstanding common stock, implying a substantial dilution of existing Techs Loanstar holders and a effectively reverse-merger style change of control. Management and governance changed at closing. Henry Fong resigned as director, President, and CEO, and G. Landon Feazell (68), Quture's Chairman and CEO, was appointed to the board and as CEO and President, with Geoffrey L. Feazell (43) named Treasurer and Secretary. Geoffrey Feazell also runs Q'Zure LLC, which develops all of Quture's technology products, which concentrates technology and management responsibility in a small family group. Shareholders approved on August 10, 2011 an increase in authorized common stock from 900 million to 2.5 billion shares, plus 10 million blank check preferred shares, to accommodate the share issuance. For investors, the filing is significant but thin on financial substance. No audited financial statements or pro forma information for Quture were included; the registrant committed to file them by amendment. The securities were issued under Section 4(2) and are restricted. The press release emphasizes growth ambitions and intellectual property, yet the filing contains no revenue, earnings, or balance sheet data for Quture, and the forward-looking statements explicitly flag the risk of going-concern issues. Investors should weigh the heavy dilution and the pending financial disclosures before drawing conclusions about value.
Bryn 8-K Report, Material Agreement (Jul 29, 2011)
Techs Loanstar, Inc. (BRRN) has filed an 8-K report announcing a significant strategic move: the company has entered into a securities exchange agreement to acquire all outstanding capital stock of Quture, Inc. This acquisition will be executed through an exchange of Techs Loanstar's common stock, with Quture's shareholders receiving 85% of Techs Loanstar's issued and outstanding common stock post-exchange. The transaction is subject to several conditions precedent, including the completion of due diligence, audited financial statements for Quture, and finalization of schedules and exhibits. This indicates a material shift in the company's structure and potential business focus, pending the successful closing of the deal. Investors should monitor the satisfaction of these conditions as they will determine the finalization of this acquisition.
Bryn 8-K/A Report, Auditor Change (Jul 21, 2010)
Byrn, Inc. (BRRN) announced a change in its independent registered public accounting firm, dismissing Seale and Beers, CPAs, and engaging RR Hawkins & Associates International, PSC, effective July 14, 2010. This change appears to be a strategic move following the company's acquisition of ZenZuu USA, Inc. on February 10, 2010, as RR Hawkins was the certifying accountant for ZenZuu USA, Inc. This allows for a more integrated accounting approach post-acquisition. Importantly, the company stated that there were no disagreements with the former auditors, Seale and Beers, CPAs, regarding accounting principles, financial statement disclosures, or auditing procedures during the past two fiscal years, the most recent nine-month period, or as of the dismissal date. Seale and Beers, CPAs did not report any reportable events. While the auditor reports from Seale and Beers, CPAs for the years ended April 30, 2009 and 2008 did not contain adverse opinions or qualifications, they did include a "going concern" paragraph, which investors should note.
Bryn 8-K Report, Auditor Change (Jul 19, 2010)
Byrn, Inc. (BRRN) has announced a change in its independent registered public accounting firm, replacing Seale and Beers, CPAs with RR Hawkins & Associates International, PSC. This change was effective on July 14, 2010, following a decision by the Company's Board of Directors. Importantly, the filing indicates that there were no disagreements between Byrn, Inc. and its former accountants, Seale and Beers, CPAs, on any significant accounting or auditing matters. Seale and Beers has also confirmed their agreement with the disclosures made in this filing. While the previous auditor's reports for the fiscal years ended April 30, 2009 and 2008 did not contain adverse opinions, they did include a "going concern" paragraph, suggesting potential doubts about the company's ability to continue as a going concern. Investors should monitor future filings for clarity on the company's financial stability.
Bryn 8-K Report, Material Agreement (Feb 17, 2010)
On February 17, 2010, Techs Loanstar, Inc. (OTC BB: TCLN) completed a reverse-merger-style share exchange with ZenZuu USA, Inc. (ZZUSA), a development-stage company holding an exclusive 10-year U.S. license to the online social network database and advertising revenue-share model of ZenZuu, Inc. (ZZI). Techs retired 28,000,000 of its 40,400,000 outstanding shares and issued 25,000,000 shares to ZZUSA's former holders, leaving approximately 37,400,000 shares outstanding. The former ZZUSA holders now control roughly 66.8% of voting power, constituting a change of control. Techs ceased its historical loan-management business and is now a shell-free operating company pursuing ZZUSA's plan. Management is Henry Fong (CEO/President) and Barry Hollander (CFO), who also serve as the entire board. The financial picture is weak. ZZUSA has essentially no revenue (nil in the six months to November 30, 2009, versus $4,774 a year earlier), a net loss of $313,687 for that six-month period, total liabilities of about $1.97 million against $850,013 in assets (mostly the license, carried net of amortization), and a stockholders' deficit of about $1.12 million. The auditor, R.R. Hawkins & Associates, included a going-concern qualification. The license carries a $1,000,000 fee, of which $450,000 was paid and $550,000 remains payable at 20% of month-end cash, plus a 25% royalty on local advertising revenue. Operations were suspended in early 2009, and the company's dependence on ZZI's ability to restart marketing is a central risk. For investors, the key issues are dilution and control. Convertible notes totaling $878,000 convert automatically six months after closing at a 35% discount to the 10-day average price, with an accelerated option at a 45% discount in the first 30 trading days. Warrants were repriced to 150% and 200% of a post-closing average price. Those conversions could issue a large number of shares at a discount, and ZZI gains the right to nominate a board majority upon note conversion or redemption. Given the going-concern doubt, minimal revenue, and heavy overhang, the filing describes a highly speculative early-stage investment.
Bryn 8-K/A Report, Auditor Change (Oct 21, 2009)
This 8-K Amendment from Byrn, Inc. (BRRN), filed on October 21, 2009, serves to re-state Item 4.01, concerning the company's certifying accountant. The primary focus of this amendment is the dismissal of Moore & Associates Chartered ("Moore") as the company's independent registered public accountants on August 6, 2009, at Moore's request. This dismissal is significant due to Moore's subsequent registration being revoked by the Public Company Accounting Oversight Board (PCAOB) on August 27, 2009, for violations of PCAOB rules and auditing standards. Following the dismissal of Moore, Byrn, Inc. engaged Seale and Beers, CPAs as its new independent auditors on the same date. While no disagreements with Moore were reported, the financial statements for the fiscal year ended April 30, 2009, contained a going concern qualification. Notably, Moore has refused to provide a letter confirming Byrn, Inc.'s statements regarding the circumstances of their dismissal, adding a layer of concern for investors regarding transparency and the former auditor's engagement.
Bryn 8-K Report, Auditor Change (Aug 10, 2009)
This Form 8-K filing for Techs Loanstar, Inc. (BRRN) reports a significant change in its auditing firm. Effective August 6, 2009, the company's Board of Directors dismissed Moore & Associates Chartered and subsequently engaged Seale and Beers, CPAs as its new independent registered public accounting firm. This change is a key event that investors should note as it may precede or coincide with other strategic or financial developments. Importantly, the filing states that there were no disagreements with the former auditor on accounting principles or financial disclosures. However, the previous auditor's report on the company's financial statements for the fiscal year ended April 30, 2009, did include a going concern qualification. This qualification indicates substantial doubt about the company's ability to continue as a going concern, a critical piece of information for assessing financial risk.
Bryn 8-K Report, Rights Modification (May 1, 2008)
Techs Loanstar, Inc. (BRRN) filed a Form 8-K on April 29, 2008, reporting a significant corporate action: an amendment to its Articles of Incorporation. This amendment authorized an increase in the number of common stock shares from 75,000,000 to 300,000,000. Concurrently, the company executed a four-for-one (4:1) forward stock split of its issued and outstanding shares. This action was effective as of April 24, 2008, for the stock split and the increase in authorized shares. Stockholder approval was not required for these changes, as permitted by Nevada state law. The filing also noted the company's new ticker symbol, 'TCLN,' which became effective on the Over-the-Counter Bulletin Board on April 29, 2008, following Nasdaq's deemed effectiveness.